Aromatic Beta-Blocker Atenolol from China
Atenolol is a synthetic aromatic beta-blocker drug used primarily for treating hypertension and angina. It falls under HTS 2942.00.05.00 as an aromatic organic compound classified as a drug, distinct from standard pharmaceuticals in Chapters 29 or 30. This code applies to specific aromatic or modified aromatic drugs not covered elsewhere.
Duty Rate — China → United States
125%
Rate breakdown
9903.88.0325%Except as provided in headings 9903.88.13, 9903.88.18, 9903.88.33, 9903.88.34, 9903.88.35, 9903.88.36, 9903.88.37, 9903.88.38, 9903.88.40, 9903.88.41, 9903.88.43, 9903.88.45, 9903.88.46, 9903.88.48, 9903.88.56, 9903.88.64, 9903.88.66, 9903.88.67, 9903.88.68, or 9903.88.69, articles the product of China, as provided for in U.S. note 20(e) to this subchapter and as provided for in the subheadings enumerated in U.S. note 20(f)
9903.04.6093.5%Pharmaceuticals: patented pharma articles — 100% floor rate
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Verify drug status with FDA registration and provide Certificate of Analysis confirming aromatic structure
• Ensure compliance with DEA scheduling if applicable; avoid misclassification as Chapter 30 finished dosage forms
• Include stability data for transport as per Chapter 29 note (f) to prevent reclassification